Replies to post #614685 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

Do you think this gentleman will continue doubling up today?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172450531

Take a look at what he once said.

buy when others are fearful, be fearful when others are buying

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171674151
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171738327

This principle only applies for smart and insightful people who know the fundamentals of the company better than anyone else. If anyone has a lot of money, he/she can simply bring Dr. Bosch's presentation to the best immunologists, especially those who did the clinical trials on dendritic cells and failed and get the best consulting. Is that something obvious enough to be done first?

[LessIsMore]

Nonocure is again down today

Novocure price target lowered to $102 from $104 at Wells Fargo

Yes, NVCR had its price target lowered today by Wells Fargo.

Can you show me one analyst who has a price target on NWBO?

Any comment on your $75 price target on NWBO for year-end 2022?